Source https://www.fightaging.org/archives/2025/04/reviewing-the-state-of-fluid-biomarker-assays-for-neurodegenerative-conditions/
The most robust measurement of pathology in neurodegenerative conditions is conducted via imaging technologies, but these don’t do well when it comes to the assessment of the more subtle earlier stages of these conditions. Further, imaging is relatively expensive. So for some years researchers have worked to develop a range of less costly, more convenient biomarkers to assess disease risk and disease progress. Progress has been made. Useful blood tests are emerging for Alzheimer’s disease, for example.
Today’s open access paper reviews recent advances and the present state of fluid biomarker assays for neurodegenerative conditions. Being able to use bodily fluids other than c…
Source https://www.fightaging.org/archives/2025/04/reviewing-the-state-of-fluid-biomarker-assays-for-neurodegenerative-conditions/
The most robust measurement of pathology in neurodegenerative conditions is conducted via imaging technologies, but these don’t do well when it comes to the assessment of the more subtle earlier stages of these conditions. Further, imaging is relatively expensive. So for some years researchers have worked to develop a range of less costly, more convenient biomarkers to assess disease risk and disease progress. Progress has been made. Useful blood tests are emerging for Alzheimer’s disease, for example.
Today’s open access paper reviews recent advances and the present state of fluid biomarker assays for neurodegenerative conditions. Being able to use bodily fluids other than c…
What Do You Think?
comments